Antonio Cano

Isoflavones and cardiovascular disease.

Sequential use of antiresorptives in younger women.

Transient regional osteoporosis.

Spanish Menopause Society position statement: Use of denosumab in postmenopausal women.

Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture.

The impact of moderate wine consumption on health.

Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases.

Deficiencies in reporting results of lesbians and gays after donor intrauterine insemination and assisted reproductive technology treatments: a review of the first emerging studies.

Personalized health care for midlife and beyond.

Cognitive frailty, a new target for healthy ageing.

Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).

Frailty and multimorbidity: Two related yet different concepts.

Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids.

Comments on the USPSTF draft recommendation statement on menopausal hormone therapy: Primary prevention of chronic conditions.

Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide.

The action of estrogens and progestogens in the young female breast.

Hormonal contraceptives and breast cancer: Clinical data.

Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level.

Tackling frailty and functional decline: Background of the action group A3 of the European innovation partnership for active and healthy ageing.

Frailty as the Future Core Business of Public Health: Report of the Activities of the A3 Action Group of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA).